InsiderTrades

Form 4 for XYL Xylem Inc.

Accepted 2026-05-08 16:15:23 ET · period of report 2026-05-07 · accession 0001524472-26-000072 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-08 16:15 2026-05-07 XYL McShane Geri-Michelle SVP, CAO M - OptEx $86.76 -3,147 7,874 -29% -$273.0K
D 2026-05-08 16:15 2026-05-07 XYL McShane Geri-Michelle SVP, CAO S - Sale+OE $117.46 -4,269 3,605 -54% -$501.4K
D 2026-05-08 16:15 2026-05-07 XYL McShane Geri-Michelle SVP, CAO M - OptEx $0.00 -3,147 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-07 M D 3,147 $86.76 7,874 D — —
2 Common Common Stock 2026-05-07 S D 4,269 $117.46 3,605 D — — (F1) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,269 Shares were executed at a range of prices from $117.42 to $118.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
3 Derivative Stock Option (Right to Buy) 2026-05-07 M D 3,147 $0.00 0 D $86.76 · — to 2032-03-01 3,147 Common Stock (F2) The March 1, 2022 option grant vested 1,049 options on March 1, 2023, 1,049 options on March 1, 2024, and 1,049 options on March 1, 2025.